Embecta Corp. (EMBC) officer purchases 20,000 shares in open-market buy

Rhea-AI Filing Summary

Embecta Corp. officer Jeffrey Z. Mann, Pres, Pharm Svc&Prod Mgmt, CLO, reported an open-market purchase of 20,000 shares of common stock on 2026-08-12 at $4.99 per share. Following this transaction, his directly held position increased to 262,915.028 shares of Embecta common stock.

Insider Trade Summary

Net Buyer: 20,000 shares

Net Buy 1 txn

Insider Mann Jeffrey Z

Role Pres, Pharm Svc&Prod Mgmt, CLO

Bought 20,000 shs ($100K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	20,000	$4.99	$100K

Holdings After Transaction: Common Stock — 262,915.028 shares (Direct)

Key Figures

Shares purchased: 20,000 shares Purchase price: $4.99 per share Total holdings after transaction: 262,915.028 shares

3 metrics

Shares purchased 20,000 shares Common Stock purchased on 2026-08-12

Purchase price $4.99 per share Price for Common Stock purchase on 2026-08-12

Total holdings after transaction 262,915.028 shares Directly held Embecta Common Stock after the reported purchase

FAQ

What insider transaction did Embecta Corp. (EMBC) disclose in this Form 4?

Embecta Corp. reported that officer Jeffrey Z. Mann purchased 20,000 shares of common stock on 2026-08-12 at $4.99 per share, increasing his directly held Embecta share position.

How many Embecta (EMBC) shares did Jeffrey Z. Mann buy and at what price?

Jeffrey Z. Mann bought 20,000 shares of Embecta common stock at a price of $4.99 per share. The transaction was reported as a purchase in an open market or private transaction.

What are Jeffrey Z. Mann’s total Embecta (EMBC) holdings after this transaction?

After the reported purchase, Jeffrey Z. Mann directly holds 262,915.028 shares of Embecta common stock. This total reflects his position immediately following the 20,000-share acquisition on 2026-08-12.

What role does Jeffrey Z. Mann hold at Embecta Corp. (EMBC)?

Jeffrey Z. Mann is an officer of Embecta Corp., serving as Pres, Pharm Svc&Prod Mgmt, CLO. His Form 4 filing reflects a personal purchase of Embecta common stock in this capacity.

Was the Embecta (EMBC) insider share transaction a buy or a sell?

The reported insider transaction was a buy. Jeffrey Z. Mann purchased 20,000 shares of Embecta common stock, and there were no reported sales in this Form 4 filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/13/2026 - 10:47 AM Accepted by SEC EDGAR 08/13/2026 - 10:47 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mann Jeffrey Z

(Last) (First) (Middle)

EMBECTA CORP.

300 KIMBALL DRIVE

(Street)

PARSIPPANY NEW JERSEY 07054

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Embecta Corp. [ EMBC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Pres, Pharm Svc&Prod Mgmt, CLO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/12/2026		P		20,000	A	$4.99	262,915.028	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Jeffrey Z. Mann	08/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)